Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5776 to 5790 of 7677 results

  1. There have been no head-to-head trials of rivaroxaban compared with a low molecular weight heparin for people who have cancer and experience an acute pulmonary embolism or deep vein thrombosis. As in NICE technology appraisal guidance 261 it is recommended that further research should be carried out.

    Recommendation ID TA287/1 Question There have been no head-to-head trials of rivaroxaban compared with a low molecular weight heparin for

    Research recommendation
    Published
    9 June 2015

  2. There is a need for additional research on the management of bleeds that occur while people are receiving apixaban, rivaroxaban or dabigatran etexilate, as there are no antidotes or established treatments to stop active bleeding for these agents.

    Recommendation ID TA275/1 Question There is a need for additional research on the management of bleeds that occur while people are receiving

    Research recommendation
    Published
    9 June 2015

  3. There is a need for further evidence on the long-term outcomes of treatment with eculizumab, and on the effect of treatment in children, adolescents and during pregnancy. The Committee supports enrolment of patients into the aHUS registry and the collection of high-quality information from these registries periodically to inform treatment decisions.

    Recommendation ID HST1/2 Question There is a need for further evidence on the long-term outcomes of treatment with eculizumab, and on the

    Research recommendation
    Published
    9 June 2015

  4. What are the benefits of a primary care-based collaborative care approach to improving the treatment of generalised anxiety disorder (GAD) compared with usual care?

    Recommendation ID CG113/5 Question What are the benefits of a primary care-based collaborative care approach to improving the treatment

    Research recommendation
    Published
    9 June 2015

  5. Clinical features for distinguishing between type 1 diabetes and other types of diabetes: What are the best clinical features or combination of features for distinguishing between type 1 diabetes and other types of diabetes?

    Recommendation ID NG17/01 Question Clinical features for distinguishing between type 1 diabetes and other types of diabetes: What are the

    Research recommendation
    Published
    11 April 2022

  6. Measuring shared decision making: What are the best ways to measure the effectiveness of shared decision making in different contexts (in different settings and involving different people)?

    Recommendation ID NG197/2 Question Measuring shared decision making: What are the best ways to measure the effectiveness of shared decision

    Research recommendation
    Published
    10 August 2021

  7. What are the causative and contributory factors underlying the persistently very low levels of reported patient satisfaction for bladder cancer?

    Recommendation ID NG2/1 Question What are the causative and contributory factors underlying the persistently very low levels of reported

    Research recommendation
    Published
    9 June 2015

  8. Diagnosing COPD: -  What are the characteristics of people diagnosed with COPD as a result of an incidental finding ofemphysema on a CT scan, compared with those diagnosed with symptoms?

    Recommendation ID NG115/6 Question Diagnosing COPD: - What are the characteristics of people diagnosed with COPD as a result of an incidental

    Research recommendation
    Published
    13 February 2019

  9. What are the clinical and cost effectiveness, and the safety, of specific antifungal treatments for treating suspected or confirmed COVID-19-associated pulmonary aspergillosis (CAPA), and the optimal treatment duration? When should treatment be started, stopped or modified?

    Recommendation ID NG191/14 Question What are the clinical and cost effectiveness, and the safety, of specific antifungal treatments for

    Research recommendation
    Published
    9 March 2022

  10. Components of a mental capacity assessment:- What are the components of an effective assessment of mental capacity to make a decision (for example checklists, memory aids or standardised documentation)?

    Recommendation ID NG108/5 Question Components of a mental capacity assessment:- What are the components of an effective assessment of mental

    Research recommendation
    Published
    18 December 2018

  11. Antibiotics for suspected early-onset infection: What are the core exposures and outcomes that should be used to evaluate clinical effectiveness of antibiotics to prevent or treat early- onset neonatal infection?

    Recommendation ID NG195/14 Question Antibiotics for suspected early-onset infection: What are the core exposures and outcomes that should

    Research recommendation
    Published
    6 August 2021

  12. Early signs of poor social, emotional and mental wellbeing: What are the early signs of social, emotional and mental wellbeing issues, including in children and young people who are internalising it? a) What early factors predict poor social, emotional and mental wellbeing? b) How do children and young people with poor social, emotional and mental wellbeing describe their thoughts and feelings at early onset stage? c) What are the barriers and facilitators to identifying children and young people at risk of poor social, emotional and mental wellbeing at school?

    Recommendation ID NG223/01 Question Early signs of poor social, emotional and mental wellbeing: What are the early signs of social, emotional

    Research recommendation
    Published
    4 August 2022

  13. Effective components of integrated regional services for people with a learning disability and behaviour that challenges:- What are the effective components of an integrated regional service for people with a learning disability and behaviour that challenges across health and social care (including pooling budgetsand other resources)?What are the barriers and facilitators to pooling budgets and other resources across regions?

    Recommendation ID NG93/4 Question Effective components of integrated regional services for people with a learning disability and behaviour

    Research recommendation
    Published
    15 November 2018

  14. Membrane sweeping: What are the effectiveness and acceptability of, and maternal satisfaction with, the following: - multiple versus once-only membrane sweeping, at varying gestational ages, depending on parity - membrane sweeping versus cervical massage?

    Recommendation ID NG207/05 Question Membrane sweeping: What are the effectiveness and acceptability of, and maternal satisfaction with

    Research recommendation
    Published
    15 December 2021

  15. Vaginal dinoprostone: What are the effectiveness, safety and maternal acceptability of: - different regimens of vaginal dinoprostone, stratified by: clinical indications; cervical and membrane status; parity; and previous caesarean birth - different management policies for unsuccessful induction of labour with vaginal dinoprostone (additional dinoprostone, oxytocin, elective caesarean birth or delay of induction, if appropriate).

    Recommendation ID NG207/06 Question Vaginal dinoprostone: What are the effectiveness, safety and maternal acceptability of: - different

    Research recommendation
    Published
    15 December 2021